Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Hisse M. van Santen, PhD, Centro Biologia Molecular Severo Ochoa, Madrid, Spain, shares his highlights from the 3rd European CAR T-cell meeting and discusses how research into CAR-T cell therapy has changed and which aspects of CAR-T cell therapy are currently being focused on. This interview took place during the 3rd European CAR T-cell Meeting.
We use necessary cookies to make this site work. Analytics, preference, and marketing cookies are used only if you choose to allow them. You can change your choice at any time. For more information view our Cookie Policy.